ABCD² Score for TIA

ورودی‌های بالینی بیمار

حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
abcd2 score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–3
  • Moderate Risk4–5
  • High Risk6–7

Clinical Decision Pathway

Clinical Decision Pathway & Next Steps

Stroke, TIA & Intracranial Hemorrhage — سکته مغزی، TIA و خونریزی داخل جمجمه

Clinical Rationale:

Risk-stratify TIA with ABCD2, quantify stroke severity with NIHSS, evaluate early CT changes with ASPECTS, measure hematoma volume with ABC/2 and mortality with ICH Score, then balance anticoagulation with CHA2DS2-VASc and HAS-BLED.

Recommended Clinical Next Steps:

  • NIH Stroke Scale/Score (NIHSS)

    مقیاس سکته NIH (NIHSS)

    Why next: Acute ischemic stroke deficit severity
  • Alberta Stroke Program Early CT Score (ASPECTS)

    امتیاز ASPECTS (تغییرات ایسکمیک در CT)

    Why next: Early MCA ischemic changes on head CT
  • ABC/2 Formula for Intracerebral Hemorrhage Volume

    فرمول ABC/2 برای حجم خونریزی داخل مغزی

    Why next: Parenchymal hematoma volume quantification
Direct Clinical Answer

The ABCD² Score for TIA calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include age. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Estimates stroke risk after a transient ischemic attack (TIA), based on patient risk factors

Clinical Indication

The ABCD² Score for TIA is indicated for bedside clinical practice to support Estimates stroke risk after a transient ischemic attack (TIA), based on patient risk factors. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis. Clinical exclusion: Not applicable for patients with established stroke.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility.

Formula & Variables:

A (Age ≥60) + B (BP ≥140/90) + C (Clinical features) + D (Duration) + D (Diabetes)

Input Parameters

NameTypeRequiredDescription
ageintegerYesPatient's age(years)
blood_pressurestringYesBlood pressure at evaluation
clinical_featuresstringYesClinical features of the episode
durationstringYesDuration of symptoms
diabetesstringYesHistory of diabetes mellitus

Score Interpretation & Guidance

RangeStageDescription
0–3Low RiskLow stroke risk
4–5Moderate RiskModerate stroke risk
6–7High RiskHigh stroke risk

Evidence-Based References (EBM)

  • Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283-92.
  • Rothwell PM, Giles MF, Flossmann E, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366(9479):29-36.

Related calculators